Medical nutrition therapy for the management of type 2 diabetes mellitus
Novel antidiabetic therapies, including sodium glucose cotransporter 2 inhibitors (SGLT2i), glucagonlike peptide-1 receptor agonists (GLP-1 RA), and glucosedependent insulinotropic polypeptide (GIP)/glucagonlike peptide-1 (GLP-1) dual receptor agonists, have demonstrated clear efficacy in the management of MetS [9,10,11]
For patients who want the IV layer on top of the at-home protocol, we offer a NAD+ plus glutathione infusion
WOLVERINE BLEND FAQ What is the Wolverine Blend
The human body is intricate, relying on a network of vitamins, minerals, and antioxidants to stay resilient
Tirzepatide works as a dual GIP and GLP-1 receptor agonist, meaning it activates two separate incretin pathways simultaneously